ArticleJournal of clinical and translational science2021
Recruiting underrepresented individuals in a double pandemic: Lessons learned in a randomized control trial.
Article in Journal of clinical and translational science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 13 citations in OpenAlex.
- "Academia Is a Very Unforgiving Space": A Qualitative Study of Challenges Faced by Under-represented Scholars in Biomedical Research.Journal of general internal medicine · 2026Article
- Strategies for recruiting participants underrepresented in clinical research: A scoping review.Social science & medicine (1982) · 2025Article
- Building Up a Biomedical Research Workforce Trial.Journal of clinical and translational science · 2025Article
- Post-doctoral fellow and faculty perceptions and experiences of inclusion at academic medical centers.Journal of clinical and translational science · 2025Article
- Mentoring as a Buffer for the Impact of Social Unrest due to Systemic Racism and Ambient Discrimination.The chronicle of mentoring & coaching · 2024Article
- The impact of inclusive mentoring and identity work on self-efficacy in career advancement and career commitment among underrepresented early-career faculty and post-doctoral fellows.Journal of clinical and translational science · 2024Article
- Inspiring diverse researchers in Virginia: Cultivating research excellence through a career-building program.Journal of clinical and translational science · 2024Article
- Inspiring Diverse Researchers in Virginia: Cultivating Research Excellence Through a Career Building Program.medRxiv : the preprint server for health sciences · 2023Article
- Perseverance and consistency of interest in underrepresented post-doctoral fellows and early-career faculty.Journal of clinical and translational science · 2023Article
- Training and cultivating the translational science workforce: Responses of Clinical and Translational Science Awards program hubs to the COVID-19 pandemic.Clinical and translational science · 2023Review
- The impact of social unrest due to systemic racism on underrepresented post-doctoral fellows and early-career faculty.Journal of clinical and translational science · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
Abstract
The Building Up Trial is a cluster-randomized trial that aims to address the issue of the leaky career pathway for underrepresented (UR) faculty in biomedical fields. Regulatory approval and recruitment for the Building Up Trial took place during the COVID-19 pandemic and the anti-racism movement. The pandemic and anti-racism movement personally and professionally impacted the target population and made recruitment challenging at both the institution and participant level. The target sample size for this study was 208 postdoctoral fellows or early-career faculty across 26 predominately white institutions. Challenges and adaptations are described. The Building Up Trial was delayed by 3 months. In total, 225 participants from 26 institutions were enrolled. Participants are predominately female (80%), Hispanic/Latinx (34%) or non-Hispanic/Latinx Black (33%), and early-career faculty (53%). At the institution level, obtaining Institutional Review Board (IRB) approval through a single Institutional Review Board (sIRB) posed the biggest challenge. We adapted to COVID-19-related challenges through simplifying sIRB forms, modifying study practices, and increasing communication with institutions. Recruiting UR postdoctoral fellows and faculty during the COVID-19 pandemic and anti-racism movement was challenging but not impossible. Studies should be prepared to modify study and recruitment policies to overcome additional barriers posed by the pandemics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.